In the previous study, Zhang et al. also showed that GAL1 induced hepatocellular carcinoma metastasis and resistance to sorafenib by upregulation of ανβ3-integrin and activated the PI3K/AKT pathway [36]. Here, AKT1 is linked to hepatocellular carcinoma.